Keywords: novartis, increase, fluvirin, production, swiss, drug, major

Novartis to increase Fluvirin production by 30%

Article | 09 July 2007

Print This

Swiss drug major Novartis' vaccines division, the second largest supplier of influenza vaccines to the US market, says it plans ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in